Epidemiology of giant cell arteritis and polymyalgia rheumatica

2009/09/29 by Miguel A. Gonzalez‐Gay, Miguel Á. González‐Gay, Tomás R. Vázquez-Rodríguez +9 · 1 citation
Medicine · #Arteritis #Dermatology #Disease #Epidemiology #Giant cell arteritis #Medicine #Otitis Media and Relapsing Polychondritis #Pathology #Polymyalgia rheumatica #Systemic Lupus Erythematosus Research #Vasculitis #Vasculitis and related conditions

paper · doi:10.1002/art.24459

openalex publication_date 2009/09/29 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Abstract

Giant cell arteritis (GCA), also called Horton or granulomatous arteritis, is a largeand medium-sized blood vessel systemic vasculitis characterized by the granulomatous involvement of the aorta and its major branches (1,2). Polymyalgia rheumatica (PMR) is a disease characterized by severe bilateral pain and aching involving the neck, shoulder, and pelvic girdles associated with morning stiffness (1). GCA and PMR mainly occur in white individuals age 50 years. Due to the progressive aging of the population in Western countries, both conditions have emerged as relatively common diseases in the elderly (1,2).

Citations

• Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty‐year period

Cited by

• Understanding the patient experience of newly diagnosed giant cell arteritis

Related

• Risk of venous and arterial thromboembolism in patients with giant cell arteritis and/or polymyalgia rheumatica: A Veterans Health Administration population‐based study in the United States
• Association between antibiotic use and the onset of giant cell arteritis and polymyalgia rheumatica: A nested case–control study from E3N‐European Prospective Investigation into Cancer and Nutrition
• Takayasu Arteritis and Giant Cell Arteritis
• Disease pattern in cranial and large-vessel giant cell arteritis
• The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis